Glycemic Response to Different Food Combinations

NCT ID: NCT05456672

Last Updated: 2023-02-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

25 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-18

Study Completion Date

2022-09-05

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess the impact of combining starch rich foods with low pH foods on the glycemic response to meals

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Low pH foods can attenuate the glycemic response to starch-rich foods. It has been demonstrated that lemon juice, due to its low pH (pH≈2.3) inhibited key digestive enzymes thereby interrupting gastric digestion of starch in vitro. This effect can significantly reduce the glycemic response in humans. In particular, adding lemon juice to a starch rich meal reduced the mean blood glucose concentration peak by 30%.

Considering the panoply of food options available, it is likely that other combinations have similar effects but no work has been conducted to develop a consolidated knowledge base to exploit this strategy. GlucoMatchMaker will go beyond the state-of-the art by addressing this knowledge gap. The main goal is to develop and test the real-life impact of pH-based food combination strategies on glycemic responses.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postprandial Glycemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dietary intervention

Dietary intervention using standardized test meals

Group Type EXPERIMENTAL

Test meals and food baskets

Intervention Type OTHER

Interventional dietary study using standardized test meals and personalized food baskets to investigate the impact of food combination on the glycemic response. The study period is organized as follows:

(Day 1: Continuous blood glucose monitoring system (CGM) activation) Days 2 and 3: Two standardized daily menus (breakfast, lunch, afternoon snack and dinner) provided on a randomized crossover basis.

Days 4 to 7: four standardized test meals, participants will be asked to substitute one meal each day (lunch or dinner) for a test meal according to a pre-defined randomization plan.

Days 8 to 10: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items.

Days 11 to 13: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items and following dietary recommendations developed by the study staff.

(Day 14: CGM sensor removed)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Test meals and food baskets

Interventional dietary study using standardized test meals and personalized food baskets to investigate the impact of food combination on the glycemic response. The study period is organized as follows:

(Day 1: Continuous blood glucose monitoring system (CGM) activation) Days 2 and 3: Two standardized daily menus (breakfast, lunch, afternoon snack and dinner) provided on a randomized crossover basis.

Days 4 to 7: four standardized test meals, participants will be asked to substitute one meal each day (lunch or dinner) for a test meal according to a pre-defined randomization plan.

Days 8 to 10: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items.

Days 11 to 13: Participants will be asked to prepare all meals using a food basket containing a mix of standardized and personal preference items and following dietary recommendations developed by the study staff.

(Day 14: CGM sensor removed)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject has given written informed consent
* Subject is available to participate in the study sessions on the proposed dates.

Exclusion Criteria

* Subject has an allergy or intolerance to any food and/or ingredient in the study meals
* Body mass index ≤ 18.5 kg/m2 or ≥ 30.0 kg/m2.
* Diagnosed mouth, throat or active gastrointestinal pathology that may affect normal ingestion and digestion of food.
* History of pancreatic disease
* Subject is immunocompromised (HIV positive, transplant patient, on antirejection medications, on a steroid for \>30 days, or chemotherapy or radiotherapy within the last year).
* Subject has Type 1 or Type 2 diabetes mellitus or pre-diabetes.
* Subject has a history of drug and/or alcohol abuse at the time of enrolment.
* Subject is currently taking medication that can effect glucose metabolism and/or normal gastrointestinal function.
* Subject is currently participating in another study, or plans to participate in another study during the study period.
* Women of child-bearing potential who do not use an acceptable method of contraception.
* Pregnant or nursing (lactating) women.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

European Union

OTHER

Sponsor Role collaborator

Hospital de Santo Espírito

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Daniela Freitas

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital de Santo Espírito da Ilha Terceira

Angra do Heroísmo, Azores, Portugal

Site Status

TERInov

Angra do Heroísmo, Azores, Portugal

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Portugal

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GlucoMatchMaker

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.